Treading on Nasdaq turf, NYSE cuts listing fees to woo biotech
By cutting its fees for companies with little to no revenue, the New York Stock Exchange (NYSE) is laying the groundwork to break Nasdaq’s strong …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.